PMC:7204657 / 468-676
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"29","span":{"begin":129,"end":140},"obj":"Chemical"},{"id":"34","span":{"begin":34,"end":54},"obj":"Disease"},{"id":"35","span":{"begin":59,"end":79},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"MESH:C502936"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:D001172"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"MESH:D013700"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"matological conditions, including rheumatoid arthritis and giant cell arteritis. Rheumatologists have extensive experience using tocilizumab; however, this may not be the case for intensivists, infectious dis"}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":65,"end":69},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"matological conditions, including rheumatoid arthritis and giant cell arteritis. Rheumatologists have extensive experience using tocilizumab; however, this may not be the case for intensivists, infectious dis"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T5","span":{"begin":34,"end":54},"obj":"Disease"},{"id":"T6","span":{"begin":45,"end":54},"obj":"Disease"},{"id":"T7","span":{"begin":59,"end":79},"obj":"Disease"},{"id":"T8","span":{"begin":70,"end":79},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005578"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0008538"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0043494"}],"text":"matological conditions, including rheumatoid arthritis and giant cell arteritis. Rheumatologists have extensive experience using tocilizumab; however, this may not be the case for intensivists, infectious dis"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":65,"end":69},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"matological conditions, including rheumatoid arthritis and giant cell arteritis. Rheumatologists have extensive experience using tocilizumab; however, this may not be the case for intensivists, infectious dis"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":129,"end":140},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"}],"text":"matological conditions, including rheumatoid arthritis and giant cell arteritis. Rheumatologists have extensive experience using tocilizumab; however, this may not be the case for intensivists, infectious dis"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T3","span":{"begin":34,"end":54},"obj":"Phenotype"},{"id":"T4","span":{"begin":70,"end":79},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0001370"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0012089"}],"text":"matological conditions, including rheumatoid arthritis and giant cell arteritis. Rheumatologists have extensive experience using tocilizumab; however, this may not be the case for intensivists, infectious dis"}